Eben Tessari
Founder presso KINIKSA PHARMACEUTICALS, LTD.
Patrimonio netto: 2 M $ in data 31/03/2024
Posizioni attive di Eben Tessari
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Chief Operating Officer | 03/01/2022 | - |
| Founder | 01/07/2015 | - | |
| Corporate Officer/Principal | 01/07/2015 | 03/01/2022 |
Storia della carriera di Eben Tessari
Precedenti posizioni note di Eben Tessari
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01/12/2014 | 01/07/2015 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Corporate Officer/Principal | 01/11/2013 | 01/12/2014 |
Formazione di Eben Tessari
| Boston University | Graduate Degree |
| Suffolk University | Graduate Degree |
| Northeastern University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Israele | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
| Chief Operating Officer | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Eben Tessari
- Esperienza
